Fig. 2From: Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitorsBenzimidazole-based multi-kinase inhibitors and their interactions in their targets’ kinase domainBack to article page